nanosynex ltd

General Data

supplementary funding
Reg Number
515609220
Sector
Biomed
Established
2015
No. of Employees
12
Stage
R&D
Additional Funding
1

Description

NanoSynex is a bioconvergent medtech startup offering a rapid, accurate, personalised diagnostic test platform for bacterial susceptibility and resistance to antibiotics.

Technology

Nanosynex' antimicrobial susceptibility test is based on a purely phenotypic approach and uses a microfluidic disposable test cartridge platform and method that optimizes bacterial growth, helping doctors to determine the most appropriate antibiotic treatment for their patients and provide same-day results.

Targeted Customers

Physicians, Clinical laboratories.

Management personnel

Diane Abensur - CEO & Co-Founder
Micha Rosen - CTO

Contact information

Name
Country
Israel
Zip
7403610

Tags

Artificial IntelligenceBiologicalsBiotechnologyHardwareLife SciencesMedTechMicrobiologySoftware

Classified Technologies

Medical Engineering

Winning details

Route name
Winning year

R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023